| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8459462 | Radiotherapy and Oncology | 2017 | 6 Pages |
Abstract
TNM staging predicts likelihood of distant metastasis, brain metastasis, and survival in LS-SCLC. This supports the routine use of TNM staging in clinical practice. The lower risk of brain metastasis in stage I and II SCLC suggests that prophylactic cranial irradiation could play a more limited role in treatment of early-stage disease.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Abraham J. Wu, Andrea Gillis, Amanda Foster, Kaitlin Woo, Zhigang Zhang, Daphna Y. Gelblum, Robert J. Downey, Kenneth E. Rosenzweig, Leonard Ong, Carmen A. Perez, M. Catherine Pietanza, Lee Krug, Charles M. Rudin, Andreas Rimner,